Literature DB >> 17786358

Identification of differential expression of genes in hepatocellular carcinoma by suppression subtractive hybridization combined cDNA microarray.

Yuefang Liu1, Xiaojing Zhu, Jin Zhu, Shibing Liao, Qi Tang, Kaikun Liu, Xiaohong Guan, Jianping Zhang, Zhenqing Feng.   

Abstract

The genetic background of hepatocellular carcinoma (HCC) has yet to be completely understood. Here, we describe the application of suppression subtractive hybridization (SSH) coupled with cDNA microarray analysis for the isolation and identification of differential expression of genes in HCC. Twenty-six known genes were validated as up-regulated and 19 known genes as down-regulated in HCC. The known genes identified were found to have diverse functions. In addition to the overexpression of AFP, these genes (increased in the presence of HCC) are involved in many processes, such as transcription and protein biosynthesis (HNRPDL, PABPC1, POLR2K, SRP9, SNRPA, and six ribosomal protein genes including RPL8, RPL14, RPL41, RPS5, RPS17, RPS24), the metabolism of lipids and proteins (FADS1, ApoA-II, ApoM, FTL), cell proliferation (Syndecan-2, and Annexin A2), and signal transduction (LRRC28 and FMR1). Additionally, a glutathione-binding protein involved in the detoxification of methylglyoxal known as GLO1 and an enzyme which increases the formation of prostaglandin E(2) known as PLA2G10 were up-regulated in HCC. Among the underexpressed genes discovered in HCC, most were responsible for liver-synthesized proteins (fibrinogen, complement species, amyloid, albumin, haptoglobin, hemopexin and orosomucoid). The enzyme implicated in the biotransformation of CYP family members (LOC644587) was decreased. The genes coding enzymes ADH1C, ALDH6A1, ALDOB, Arginase and CES1 were also found. Additionally, we isolated a zinc transporter (Zip14) and a function-unknown gene named ZBTB11 (Zinc finger and BTB domain containing 11) which were underexpressed, and seven expression sequence tags deregulated in HCC without significant homology reported in the public database. Essentially, by using SSH combined with a cDNA microarray we have identified a number of genes associated with HCC, most of which have not been previously reported. Further characterization of these differentially expressed genes will provide information useful in understanding the genes responsible for the development of HCC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17786358

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  53 in total

Review 1.  The status of zinc in the development of hepatocellular cancer: an important, but neglected, clinically established relationship.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  Cancer Biol Ther       Date:  2014-01-21       Impact factor: 4.742

Review 2.  The Multiple Faces of the Metal Transporter ZIP14 (SLC39A14).

Authors:  Tolunay B Aydemir; Robert J Cousins
Journal:  J Nutr       Date:  2018-02-01       Impact factor: 4.798

3.  Unique genomic profile of fibrolamellar hepatocellular carcinoma.

Authors:  Helena Cornella; Clara Alsinet; Sergi Sayols; Zhongyang Zhang; Ke Hao; Laia Cabellos; Yujin Hoshida; Augusto Villanueva; Swan Thung; Stephen C Ward; Leonardo Rodriguez-Carunchio; Maria Vila-Casadesús; Sandrine Imbeaud; Anja Lachenmayer; Alberto Quaglia; David M Nagorney; Beatriz Minguez; Flair Carrilho; Lewis R Roberts; Samuel Waxman; Vincenzo Mazzaferro; Myron Schwartz; Manel Esteller; Nigel D Heaton; Jessica Zucman-Rossi; Josep M Llovet
Journal:  Gastroenterology       Date:  2014-12-31       Impact factor: 22.682

4.  SNRPA enhances tumour cell growth in gastric cancer through modulating NGF expression.

Authors:  Ning Dou; Dong Yang; Shijun Yu; Binghao Wu; Yong Gao; Yandong Li
Journal:  Cell Prolif       Date:  2018-07-24       Impact factor: 6.831

5.  Genes with relevance for early to late progression of colon carcinoma based on combined genomic and transcriptomic information from the same patients.

Authors:  Kristina K Lagerstedt; Erik Kristiansson; Christina Lönnroth; Marianne Andersson; Britt-Marie Iresjö; Annika Gustafsson; Elisabeth Hansson; Ulf Kressner; Svante Nordgren; Fredrik Enlund; Kent Lundholm
Journal:  Cancer Inform       Date:  2010-04-23

6.  Proteomic expression analysis of surgical human colorectal cancer tissues: up-regulation of PSB7, PRDX1, and SRP9 and hypoxic adaptation in cancer.

Authors:  Jung-hyun Rho; Shuzhen Qin; Julia Y Wang; Michael H A Roehrl
Journal:  J Proteome Res       Date:  2008-06-13       Impact factor: 4.466

Review 7.  Fragile X-related protein family: a double-edged sword in neurodevelopmental disorders and cancer.

Authors:  Mrinmoyee Majumder; Roger H Johnson; Viswanathan Palanisamy
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-09-02       Impact factor: 8.250

8.  Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics study.

Authors:  Dominik A Megger; Thilo Bracht; Michael Kohl; Maike Ahrens; Wael Naboulsi; Frank Weber; Andreas-Claudius Hoffmann; Christian Stephan; Katja Kuhlmann; Martin Eisenacher; Jörg F Schlaak; Hideo A Baba; Helmut E Meyer; Barbara Sitek
Journal:  Mol Cell Proteomics       Date:  2013-03-05       Impact factor: 5.911

Review 9.  The RNA-binding fragile-X mental retardation protein and its role beyond the brain.

Authors:  Cassandra Malecki; Brett D Hambly; Richmond W Jeremy; Elizabeth N Robertson
Journal:  Biophys Rev       Date:  2020-07-11

10.  Molecular signature of cell cycle exit induced in human T lymphoblasts by IL-2 withdrawal.

Authors:  Magdalena Chechlinska; Jan Konrad Siwicki; Monika Gos; Malgorzata Oczko-Wojciechowska; Michal Jarzab; Aleksandra Pfeifer; Barbara Jarzab; Jan Steffen
Journal:  BMC Genomics       Date:  2009-06-08       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.